Evidence map›Paper›PMID 26688694›Full record

ArticleJournal of drug delivery science and technology2015

POLYMERIC BIOMATERIALS AND NANOMEDICINES.

Jiyuan Yang, Jindřich Kopeček

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of drug delivery science and technology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Polymer nanomedicines.Advanced drug delivery reviews · 2020
    Review
  3. Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  4. Article
  5. Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jiyuan YangDepartment of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah 84112, USA.
Jindřich KopečekDepartment of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah 84112, USA ; Department of Bioengineering, University of Utah, Salt Lake City, Utah 84112, USA.
University of Utah · US

Funding

POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPYR01CA051578 · NCI · UNIVERSITY OF UTAH · PI KOPECEK, JINDRICH H. · 1992 to 2010
$2.8M
Drug-Free Macromolecular TherapeuticsR01GM095606 · NIGMS · UNIVERSITY OF UTAH · PI KOPECEK, JINDRICH H. · 2011 to 2018
$2.3M
BONE TARGETED DELIVERY OF ANABOLIC AGENTSR01GM069847 · NIGMS · UNIVERSITY OF UTAH · PI KOPECEK, JINDRICH H. · 2004 to 2011
$2.3M
DOUBLE-TARGETED MACROMOLECULAR THERAPEUTICS FOR THE TREATMENT OF PROSTATE CANCERR01CA132831 · NCI · UNIVERSITY OF UTAH · PI KOPECEK, JINDRICH H. · 2008 to 2012
$1.5M
HYBRID HYDROGELS SELF-ASSEMBLED FROM GRAFT COPOLYMERSR01EB005288 · NIBIB · UNIVERSITY OF UTAH · PI KOPECEK, JINDRICH H. · 2005 to 2008
$1.2M
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian CancerR42CA156933 · NCI · THERATARGET · PI KOPECEK, JINDRICH H. · 2014 to 2015
$995k
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian CancerR41CA156933 · NCI · THERATARGET · PI CHENEY, DARWIN LEROY, KOPECEK, JINDRICH H. · 2011 to 2011
$148k
IMMUNOCHEMOTHERAPY FOR OVARIAN CANCERR03TW006260 · FIC · UNIVERSITY OF UTAH · PI KOPECEK, JINDRICH H. · 2005 to 2007
$117k
FIC NIH HHS R03 TW006260NCI NIH HHS R01 CA051578NCI NIH HHS R01 CA132831NCI NIH HHS R41 CA156933NCI NIH HHS R42 CA156933NIBIB NIH HHS R01 EB005288NIGMS NIH HHS R01 GM069847NIGMS NIH HHS R01 GM095606
6 · The paper itself

Abstract

This overview intends to demonstrate the close relationship between the design of smart biomaterials and water-soluble polymer-drug conjugates. First, the discovery and systematic studies of hydrogels based on crosslinked poly(meth)acrylic acid esters and substituted amides is described. Then, the lessons learned for the design of water-soluble polymers as drug carriers are highlighted. The current state-of-the-art in water-soluble, mainly poly[

Indexed as

CancerDrug-free macromolecular therapeuticsHydrogelsNanomedicinesPolymer-drug conjugatesSelf-assembly of macromolecules

Identifiers

PMID26688694
PMCPMC4681002
OpenAlexW257747459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.